Targeting tissue angiotensin-converting enzyme for imaging cardiopulmonary fibrosis.

Current Cardiology Reports
Omer Aras, Vasken Dilsizian

Abstract

Convincing clinical and experimental evidence exists that the renin-angiotensin system and its primary effector peptide, angiotensin II, are linked to the pathophysiology of interstitial fibrosis in the heart and in the lung. Tissue angiotensin-converting enzyme and locally synthesized angiotensin II exert local trophic effects, which regulate fibroblast growth and proliferation. Thus, the presence of tissue renin-angiotensin system offers an opportunity for targeted imaging, which may be valuable for understanding the pathobiology of cardiopulmonary disorders and for guiding medical therapy.

References

Oct 1, 1992·The American Journal of Physiology·D E DostalK M Baker
Sep 1, 1986·Proceedings of the Society for Experimental Biology and Medicine·A MolteniN H Solliday
Oct 17, 1998·Biochemical Pharmacology·N VenkatesanG Chandrakasan
May 26, 1999·Current Topics in Pathology. Ergebnisse Der Pathologie·J GauldieG M Tremblay
Apr 25, 2000·The Journal of Laboratory and Clinical Medicine·Y SunS Lamparter
Jun 14, 2000·American Journal of Respiratory and Critical Care Medicine·R P MarshallG J Laurent
Jul 13, 2000·American Journal of Physiology. Lung Cellular and Molecular Physiology·R WangB D Uhal
Sep 19, 2000·British Journal of Pharmacology·D PunithavathiM Babu
May 19, 2001·Clinical Immunology : the Official Journal of the Clinical Immunology Society·P J Sime, K M O'Reilly
Sep 22, 2001·Hypertension·S A MezzanoJ Egido
Oct 5, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H YoshijiH Fukui
Jun 8, 2002·Biochemical and Biophysical Research Communications·Yun Zhao, Dawn A Geverd
Jun 21, 2002·Nature·Michael A CrackowerJosef M Penninger
Nov 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kemin ChenHelen Braley-Mullen
Feb 7, 2003·Current Pharmaceutical Design·Rajko Igić, Rahim Behnia
Feb 7, 2003·Current Pharmaceutical Design·Richard P Marshall
May 20, 2003·American Journal of Physiology. Lung Cellular and Molecular Physiology·Richard P MarshallGeoffrey J Laurent
Aug 14, 2003·Genome Biology·James F Riordan
Oct 25, 2003·European Journal of Pharmacology·Yoshiaki TomimoriYoshiaki Fukuda
Nov 25, 2003·The American Journal of Pathology·Xiaopeng LiBruce D Uhal
Jan 30, 2004·Annual Review of Medicine·Victor J ThannickalFernando J Martinez
Jun 11, 2004·European Journal of Pharmacology·Masato SakaguchiMizuo Miyazaki
Aug 3, 2004·Nature Reviews. Immunology·Thomas A Wynn
Nov 19, 2004·Cellular and Molecular Life Sciences : CMLS·U DanilczykJ M Penninger
Jul 8, 2005·Nature·Yumiko ImaiJosef M Penninger
Jul 13, 2005·Progress in Biophysics and Molecular Biology·Shant Der SarkissianMohan K Raizada
Aug 2, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Carlos M FerrarioJewell A Jessup
Dec 27, 2005·International Journal of Radiation Oncology, Biology, Physics·Mike E Robbins, Debra I Diz
Apr 4, 2006·Current Opinion in Pharmacology·Keiji KubaJosef M Penninger
Nov 17, 2006·The European Respiratory Journal·M AdamzikW Siffert

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.